Saturday, July 11, 2026
🇺🇸 FDA

Drug profile · INN

regimen

regimen is an FDA-listed pharmaceutical active ingredient.

NMPA: clinical trials
Patents linked 20
Pipeline programs 52
News articles 0
Drug details — regimen
Class
—
Route
—
Patents
20
Programs
52
Data quality
0.70
← All drugs Related patents Pipeline programs Drug news hub Event calendar

Quick answer

regimen is an FDA-listed pharmaceutical active ingredient.

Key facts

INN regimen

Approval history

Authority Status Date
NMPA clinical trials —

Pipeline programs

Browse pipeline
  1. CL3-95031-007 Phase 3 · George Institute for · Locally advanced or metastatic conventional chondrosarcoma w
  2. CMF regimen Phase 3 · United Therapeutics Europe · Breast Cancer
  3. DIDaC/ NVALT35 Phase 3 · Disc Medicine · Patients with advanced, metastatic NSCLC that have not progr
  4. DLY201619 Phase 3 · Chinese Academy of · Non-small Cell Lung Cancer Stage IIIA
  5. Decitabine plus HAAG regimen Phase 3 · First People's Hospital · Acute Myeloid Leukemia
  6. IAC regimen Phase 3 · First People's Hospital · Acute Myeloid Leukemia
  7. 2023-SR-002 Phase 2 · First People's Hospital · NK-T-Cell Lymphoma, Extranodal
  8. 209628 Phase 2 · GSK Glaxo Smith · Multiple Myeloma

Related patents

Browse patents

  1. US 20260060930

    New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases

    Expires Wed Feb 28 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12410153

    Compounds, compositions and methods

    Expires Mon Sep 04 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12390463

    Dosage forms and regimens for amino acid compounds

    Expires Mon Aug 14 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 12364683

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon Jul 17 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 12343381

    Dosage regimen for pegylated interferon

    Expires Mon Jun 26 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 12336980

    Dosing regimen for a selective S1P1 receptor agonist

    Expires Mon Jun 19 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 12138247

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon Nov 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 12109196

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon Oct 03 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 12090140

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon Sep 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 12029788

    Methods for increasing lean body mass with an exercise regimen and a GDF8 inhibitor that is an anti-GDF8 antibody

    Expires Mon Jul 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11998528

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 11998529

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon May 30 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 11939368

    QTY Fc fusion receptor proteins

    Expires Mon Mar 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 11918627

    Dosage regimen for inhaled vasoactive intestinal polypeptide

    Expires Mon Feb 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 11903994

    Dosing regimens

    Expires Mon Feb 15 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 11890272

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon Feb 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 11850243

    Dihydropyridine compositions and methods for treating neurological disorders

    Expires Mon Dec 21 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 11806334

    Non-sedating dexmedetomidine treatment regimens

    Expires Mon Nov 02 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 2023321198

    Dosage Regimen for a Controlled-Release PTH Compound

    Expires Wed Oct 07 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 11749394

    Method and apparatus for providing a pharmacokinetic drug dosing regimen

    Expires Mon Aug 31 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is regimen?

regimen is an FDA-listed pharmaceutical active ingredient.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.